J. Goldman & CO LP Regenxbio Inc. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$24.05 - $37.5 $1.34 Million - $2.1 Million	-55,911 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$26.0 - $34.6 $496,314 - $660,479	-19,089 Reduced 25.45%	55,911 $1.86 Million
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $1.35 Million - $2.47 Million	75,000	75,000 $2.47 Million

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.